Aged male and female spontaneously hypertensive rats benefit from n-3 polyunsaturated fatty acids supplementation

Physiological Research

Volumn 57, Issue SUPPL. 2, 2008, Pages

  Mitasikova M ^a   Smidova S ^b   Macsaliova A ^a   Knezl, V ^c   Dlugosova K ^a   Okruhlicova L' ^a   Weismann, P ^b   Tribulová, Narcis ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Connexin 43; DPPIV; Myocardial enzymes; n 3 PUFA; SHR; Ultrastructure; Ventricular fibrillation

Indexed keywords

EID: 45849119402     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. BALK EM, LICHTENSTEIN AH, CHUNG M, KUPELNICEK B, CHEW P, LAU J: Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk. Atherosclerosis 189: 19-30, 2006.
2. BILLMAN GE, KANG JX, LEAF A: Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circ 99: 2452-2457, 1999.
3. BING OHL, BROOKS WW, ROBINSON KG, SLAWSKY MT, HAYES JA, LITWIN SE, SEN S, CONRAD CH: The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol 27: 383-396, 1995.
4. BOERIGHTER G, COSTELLO-BOERIGTER LC, HARTY GJ, LAPP H, BURNETT JC: Des-serine-proline B-type natriuretic peptide (BNP 3-32) in cardiorenal regulation. Am J Physiol 292: R897-901, 2007.
5. BORDONI A, ASTOLFI A, MORANDI L, PESSION A, DANESI F, DI NUNZIO M, FRANZONI M, BIAGI PL, PESION A: N-3 PUFAs modulate global gene expression profile in cultured rat cardiomyocytes. Implication in cardiac hypetrophy and heart failure. FEBS Letters 581: 923-929, 2007.
6. CHAMPEIL-POTOKAR G, CHAUMONTET C, GUESNET P, LAVIALLE M, DENIS I: Docosahexaenoic acid (22:6n-3) enrichment of membrane phospholipids increases gap junction coupling capacity in cultured astrocytes. Eur J Neurosci 24: 3084-3090, 2006.
7. DAVIDSON MH: Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Amer J Cardiol 98: 27i-33i, 2006.
8. DE GROOT JR, CORONEL R: Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis. Cardiovasc Res 62: 323-334, 2004.
9. DEN RUIJTER HM, BERECKI G, OPTHOF T, VERKERK AO, ZOCK PL, CORONEL R: Pro- and antiarrhytmic properties of a diet rich in fish oil. Cardiovasc Res 73: 316-325, 2007.
10. DHEIN S, MICHAELIS B, MOHR FW: Antiarrhythmic and electrophysiological effect of long-chain ω-3 polyunsaturated fatty acids. Arch Pharmacol 371: 202-211, 2005.
11. FIALOVÁ M, DLUGOŠOVÁ K, OKRUHLICOVÁ L', KRISTEK F, MANOACH M, TRIBULOVÁ N: Adaptation of the heart to hypertension is associated with maladaptive gap junction connexin-43 remodelling. Phys Res in press (2007).
12. HARRIS WS: Omega-3 fatty acids and cardiovascular disease: A case for omega-3 index as a new risk factor. Pharmacol Res 55: 217-223, 2007.
13. HONEN BN, SAINT DA, LAVER DR: Suppression of calcium sparks in rat ventricular myocytes and direct inhibition of sheep cardiac RyR channels by EPA, DHA and Oleic acid. J Membrane Biol 196: 95-103, 2003.
14. 2+ dynamics and antioxidant status. Free Radical Biol Med 40: 1592-1602, 2006.
15. 2+)-ATPase activity. Jap Circ J 58: 903-912, 1994.
16. KOSTIN S, DAMMER S, HEIN S: Connexin 43 expression and distribution in compensated and decompensated cardiac hypetrophy in patients with aortic stenosis. Cardiovasc Res 62: 426- 436, 2004.
17. KOYAMA T, XIE Z, GAO M, SUZUKI J, BATRA S: Adaptive changes in the capillary network in the left ventricle of rat heart. Jap J Physiol 48: 229-241, 1998.
18. LAMBEIR AM, DURINX C, SCHARPE S, DE MEESTER I: Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 40(3): 209-294, 2003.
19. LEAF A, WEBER PC: Cardiovascular effects of N-3 fatty acids. N Engl J Med 318: 549-557, 1988.
20. LEAF A, XIAO YF, KANG JX, BILLMAN GE: Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. Pharmac&Therapeut 98: 355-377, 2003.
21. LEE KW, LIP GYH: The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. Q J Med 96: 465-480, 2003.
22. LEIFERT WR, DORIAN CL, JAHANGIRI A, MC MURCHIE EJ: Dietary fish oil prevents asynchronous contractility and alters Ca2+ handling in adult rat cardiomyocytes. J Nutr Biochem 12: 365-76, 2001.
23. LENDECKEL U, ARNDT M, WRENGER S, NEPPLE K, HUTH CH, ANSORGE S, KLEIN HU, GOETTE A: Expression and activity of ectopeptidases in fibrillating human atria. J Moll Cell Cardiol 33: 1273-1281, 2001.
24. LOJDA Z: Studies on dipeptidyl (amino) peptidase IV. Histochemistry 59:153-166, 1979.
25. MAZGALEV TN: Drugs, ablation, denervation and now fish oil: the global war on AF. J Cardiovasc Electrophysiol 16: 1195-1199, 2005.
26. MOZAFFARIAN D, PRINEAS RJ, STEIN PK, SISKOVICK DS: Dietary fish and n-3fatty acid intake and cardiac electrocardiographic parameters in human. J Amer Coll Cardiol 48: 478-84, 2006.
27. REIFFEL JA, MC DONALD A: Antiarrhytmic effects of omega-3 fatty acids. Am J Cardiol 98: 50-60, 2006.
28. SACKS FM, KATAN M: Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med 113(9B): 13-24, 2002.
29. SAFFITZ J, SCHUESSLER RB, YAMADA KA ..: Mechanisms of remodelling of gap junction distribution and the development of anatomic substrates of arrhythmias. Cardiovasc Res 42: 309-317, 1999.
30. SISKOVICK DS, LEMAITRE RN, MOZAFFARIAN D: A diet-heart hypothesis with clinical implications: n-3 polyunsaturated fatty acids, myocardial vulnerability and sudden death. Circulation 107: 2632-2634, 2003.
31. SPACH MS, HEIDLAGE JF: The stochastic nature of cardiac propagation at a microscopic level. An electrical description of myocardial architecture and its application to conduction. Circ Res 76: 366-380, 1995.
32. TAMURA T, SAID S, GERDES M: Gender-related differencers in myocyte remodeling in progression to heart failure. Hypertension 33: 676-680, 1999.
33. TEUNISSEN BEJ, JONGSMA HJ, BIERHUIZEN MFA: Regulation of myocardial connexins during hypertrophic remodelling. Eur Heart J 25: 1979-1989, 2004.
34. TRIBULOVA N, KNEZL V, FIALOVA M, DLUGOSOVA K, OKRUHLICOVA L: Fish oil likewise atorvastatin decreases susceptibility of hypertriglyceridemic rat heart to ventricular fibrillation. Eur Heart J 28: 29 abstract, 2007.
35. +-induced arrhytmias. Gen Physiol Biophys 22: 369-382, 2003.
36. TRIBULOVA N, OKRUHLICOVA L, NOVAKOVA S, PANCZA D, BERNATOVA I, PECHANOVA O, WEISMANN P, MANOACH M, SEKI S, MOCHIZUKI S: Hypertension-related intermyocyte junction remodelling is associated with a higher incidence of low-K(+)-induced lethal arrhythmias in isolated rat heart. Exp Physiol 87: 195-205, 2002.
37. TRIBULOVÁ N, OKRUHLICOVÁ L', VARON D, MANOACH M, PECHANOVÁ O, BERNÁTOVÁ I, WEISMANN P, BARANČÍ K M, STYK J, SLEZÁK J: Structural substrates involved in the development of severe arrhythmias in hypertensive rat and aged guinea pig hearts. In:Cardiac Remodelling and failure. SINGAL P, DIXON I, KIRSCHENBAUM L, DHALLA NS (eds.), Kluwer Acad Publishers, Boston 2002a, pp. 377-398.
38. VON SCHACKY C, HARRIS WS: Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res 73: 310-315, 2007.
39. VLKOVIČOVÁ J, JAVORKOVÁ V, PECHÁŇ OVÁ O, VRBJAR N: Gender difference in functional properties of Na,K-ATPase in the heart of spontaneously hypertensive rats. Life Sci 76: 971-982, 2005.
40. ZICHA L, PECHÁŇOVÁ O, ČAČÁ NYIOVÁ S, CEBOVÁ M, KRISTEK F, TOcombining double acute accent ROcombining double acute accent K J, IMKO F, DOBEŠOVÁ Z, KUNEŠ J: Hereditary hypertriglyceridemic rat: A suitable model of cardiovascular disease and metabolic syndrome? Phys Res 55: 49-63, 2006.